Related Experiment Videos
Antiviral activity of aliphatic nucleoside analogues: structure-function relationship
Journal of Medicinal Chemistry
|May 1, 1979
Summary
The antiviral compound (S)-9-(2,3-dihydroxypropyl)adenine [(S)-DHPA] shows significant activity against vaccinia and vesicular stomatitis viruses. It effectively inhibits viral replication at low concentrations, unlike other nucleoside analogues tested.
Area of Science:
- Virology
- Medicinal Chemistry
- Nucleoside Analogues
Background:
- Nucleoside analogues are investigated for antiviral properties.
- Aliphatic nucleoside analogues offer diverse chemical structures for drug discovery.
- Viral infections necessitate the development of novel antiviral agents.
Purpose of the Study:
- To identify potent antiviral agents from a series of aliphatic nucleoside analogues.
- To evaluate the antiviral efficacy of (S)-9-(2,3-dihydroxypropyl)adenine [(S)-DHPA] and related compounds.
- To determine the inhibitory concentrations of active analogues against specific viruses.
Main Methods:
- Synthesis and screening of 58 aliphatic nucleoside analogues.
- Antiviral assays using primary rabbit kidney cell cultures.
- Challenging cell cultures with vaccinia virus and vesicular stomatitis virus.
- Determining effective concentrations for viral replication inhibition.
Main Results:
- (S)-DHPA demonstrated the highest antiviral activity among the tested analogues.
- (S)-DHPA inhibited vaccinia and vesicular stomatitis virus replication at 0.05-0.1 mM.
- Other analogues showed limited or no antiviral activity at 2 mM, with some exceptions at 0.5-1 mM.
Conclusions:
- (S)-DHPA is a highly promising antiviral candidate for vaccinia and vesicular stomatitis viruses.
- The structural features of (S)-DHPA contribute to its potent antiviral effects.
- Further research into DHPA analogues may yield broader-spectrum antiviral therapies.